Article Text

Download PDFPDF
Prevalence of spondyloarthritis in Serbia: a EULAR endorsed study
  1. Mirjana I Zlatkovic-Svenda1,
  2. Roksanda M Stojanovic1,
  3. Sandra B Sipetic-Grujicic2,
  4. Marija M Radak-Perovic1,
  5. Nemanja S Damjanov1,
  6. Francis Guillemin3
  1. 1Institute of Rheumatology, University of Belgrade School of Medicine, Belgrade, Serbia
  2. 2Institute of Epidemiology, University of Belgrade School of Medicine, Belgrade, Serbia
  3. 3INSERM—CIC-EC, Department of Clinical Epidemiology and Evaluation, University Hospital, and Université de Lorraine, EA 4360 APEMAC, Nancy, France
  1. Correspondence to Dr Mirjana Zlatkovic-Svenda, Institute of Rheumatology, Resavska 69, 11000 Belgrade, Serbia; mirjanazlatkovicsvenda{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

In order to determine the burden of inflammatory rheumatic diseases across Europe, the European League Against Rheumatism (EULAR) unique-methodology prevalence survey of rheumatoid arthritis (RA) and spondyloarthritis (SpA) was carried out in several European countries, including Serbia. Aiming to enable comparable results, it comprised a common two-stage approach: a detection phase (validated screening telephone questionnaire, primarily tested in France1 ,2) and a confirmation phase (according to a certified rheumatologist or, for previously non-diagnosed cases, a rheumatology examination).

The Serbian SpA prevalence survey was conducted by 30 trained interviewers on urban population in four Serbian towns: Belgrade (north), and Čačak, Kruševac and Užice (south), by telephone (every 100th telephone number) from April to October 2008. The sample covered 36.5% of the total Serbian population with more than 99% Caucasians, mostly orthodox Serbs (83%), <4% Hungarians, Gypsies and Bosnians and a minority of other nationalities. Respondents were asked whether they have (or …

View Full Text


  • Funding This work was supported by a EULAR grant, under the EULAR prevalence survey of rheumatoid arthritis and spondyloarthropathy, endorsed by the EULAR Standing Committee of Epidemiology and Health Service Research.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval Ethics Committee, Institute of Rheumatology, University of Belgrade, Serbia.

  • Provenance and peer review Not commissioned; externally peer reviewed.